Literature DB >> 12721341

Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years.

Lars Peterson1, Tom Minas, Mats Brittberg, Anders Lindahl.   

Abstract

BACKGROUND: Osteochondritis dissecans of the knee is a challenging clinical problem. We previously reported on the early successful results of autologous chondrocyte transplantation for the treatment of focal cartilage defects. The purpose of the present study was to assess the intermediate to long-term results of this technique in a large group of patients with osteochondritis dissecans.
METHODS: Fifty-eight patients with radiographically documented osteochondritis dissecans of the knee underwent treatment with autologous chondrocyte transplantation between 1987 and 2000 and were assessed clinically with use of standard rating scales. Twenty-two patients consented to arthroscopic second-look evaluation of graft integrity.
RESULTS: The mean age of the patients at the time of autologous chondrocyte transplantation was 26.4 years (range, fourteen to fifty-two years). Seven patients were less than eighteen years old. Thirty-five patients (60%) had juvenile-onset disease, and forty-eight patients (83%) had had a mean of 2.1 prior operations. The defect was located on the medial femoral condyle in thirty-nine patients and on the lateral femoral condyle in nineteen. The mean lesion size was 5.7 cm (2) (range, 1.5 to 12.0 cm (2) ), and the mean defect depth was 7.8 mm (range, 4 to 15 mm). After a mean duration of follow-up of 5.6 years, 91% of the patients had a good or excellent overall rating on the basis of a clinician evaluation and 93% had improvement on a patient self-assessment questionnaire. The Tegner-Wallgren, Lysholm, and Brittberg-Peterson VAS scores were all improved. The macroscopic quality of graft integrity averaged 11.2 on a 12-point scale, with only one graft having a score of <9 points. Two patients had a failure of treatment in the early postoperative period. Only one patient who had had a good or excellent rating at two years had a decline in clinical status at the time of the latest follow-up.
CONCLUSIONS: Treatment of osteochondritis dissecans lesions of the knee with autologous chondrocyte transplantation produces an integrated repair tissue with a successful clinical result in >90% of patients. We recommend the wider use of autologous chondrocyte transplantation for this condition.

Entities:  

Mesh:

Year:  2003        PMID: 12721341     DOI: 10.2106/00004623-200300002-00003

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  116 in total

Review 1.  Hydrogels for the repair of articular cartilage defects.

Authors:  Kara L Spiller; Suzanne A Maher; Anthony M Lowman
Journal:  Tissue Eng Part B Rev       Date:  2011-06-30       Impact factor: 6.389

2.  In vitro chondrogenic phenotype differentiation of bone marrow-derived mesenchymal stem cells.

Authors:  Yufu Zhang; Changyong Wang; Wen Liao; Zhanghua Li; Ximin Guo; Qiang Zhao; Cuimi Duan; Renyun Xia
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 3.  Surgical treatment for early osteoarthritis. Part I: cartilage repair procedures.

Authors:  A H Gomoll; G Filardo; L de Girolamo; J Espregueira-Mendes; J Esprequeira-Mendes; M Marcacci; W G Rodkey; J R Steadman; R J Steadman; S Zaffagnini; E Kon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-24       Impact factor: 4.342

4.  Potential of exogenous cartilage proteoglycan as a new material for cartilage regeneration.

Authors:  Shusa Ohshika; Yasuyuki Ishibashi; Atsushi Kon; Tomomi Kusumi; Hiroshi Kijima; Satoshi Toh
Journal:  Int Orthop       Date:  2011-08-12       Impact factor: 3.075

Review 5.  Osteochondritis Dissecans: Etiology, Pathology, and Imaging with a Special Focus on the Knee Joint.

Authors:  Juergen Bruns; Mathias Werner; Christian Habermann
Journal:  Cartilage       Date:  2017-06-22       Impact factor: 4.634

Review 6.  Challenges in tissue engineering.

Authors:  Yoshito Ikada
Journal:  J R Soc Interface       Date:  2006-10-22       Impact factor: 4.118

7.  Good clinical results but moderate osseointegration and defect filling of a cell-free multi-layered nano-composite scaffold for treatment of osteochondral lesions of the knee.

Authors:  Dominic T Mathis; Raphael Kaelin; Helmut Rasch; Markus P Arnold; Michael T Hirschmann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-07-15       Impact factor: 4.342

8.  Autologous chondrocyte transplantation for the treatment of massive cartilage lesion of the distal tibia: a case report with 8-year follow-up.

Authors:  Atsuo Nakamae; Lars Engebretsen; Lars Peterson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-09-15       Impact factor: 4.342

9.  Growing cartilage for human replacement-where are we?

Authors:  Anders Lindahl
Journal:  Skeletal Radiol       Date:  2008-04       Impact factor: 2.199

10.  Cell quality affects clinical outcome after MACI procedure for cartilage injury of the knee.

Authors:  Matthias F Pietschmann; Annie Horng; Thomas Niethammer; Isa Pagenstert; Birte Sievers; Volkmar Jansson; Christian Glaser; Peter E Müller
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-06-10       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.